• In the past quarter, UniFirst Corporation reported second-quarter 2026 sales of US$622.51 million, up from US$602.22 million a year earlier, while net income declined to US$20.48 million and diluted earnings per share from continuing operations fell to US$1.13.
• Over the first six months of fiscal 2026, UniFirst grew sales to US$1,243.82 million but saw net income and diluted earnings per share from continuing operations fall to US$54.85 million and US$3.02 respectively, highlighting that revenue gains are currently coming with reduced profitability.
• With sales rising but earnings and margins under pressure, we’ll now examine how this mixed performance affects UniFirst’s investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource.

UniFirst Investment Narrative Recap

To own UniFirst, you need to believe that consistent uniform and facility service demand, plus ongoing operational improvements, can eventually translate revenue gains into healthier earnings. The latest quarter supports the demand side, with sales edging higher, but weaker net income keeps margin pressure as the key near term risk. This earnings softness does not appear to materially change the primary short term catalyst, which remains execution on cost controls and efficiency initiatives.

The recent update on UniFirst’s share repurchase program is particularly relevant alongside these results. The company has completed US$91.49 million of buybacks, retiring 2.88% of its shares, but did not repurchase any stock in the most recent period. With earnings under pressure, how UniFirst balances future buybacks against reinvestment and margin improvement efforts could be important for shareholders watching both capital allocation and profitability.

Yet behind the steady revenue growth, investors should be aware that rising health care costs and margin pressure could still...

UniFirst's narrative projects $2.7 billion revenue and $165.1 million earnings by 2029. This requires 3.4% yearly revenue growth and about a $29.5 million earnings increase from $135.6 million today.

Uncover how UniFirst's forecasts yield a $279.00 fair value, a 9% upside to its current price.

Exploring Other Perspectives

Before this earnings release, the most pessimistic analysts were assuming UniFirst could reach about US$2.7 billion of revenue and roughly US$162.8 million of earnings by 2029, but your own view on execution risk, especially around ERP and cost control, might differ quite a bit from that.

Explore 3 other fair value estimates on UniFirst - why the stock might be worth as much as 9% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your UniFirst research is our analysis highlighting 1 key reward that could impact your investment decision.
• Our free UniFirst research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate UniFirst's overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 33 elite penny stocks that balance risk and reward.
• Outshine the giants: these 21 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.